Porvenir · Content for Pharmaceutical & Biotech Companies
Content Not Driving Traffic
for
Pharmaceutical & Biotech Companies.
You're publishing regularly. It's just not moving the needle.
Fixed for pharmaceutical & biotech companies. Pharmaceutical and biotech companies must build scientific credibility and investor confidence simultaneously.
Signs pharmaceutical & biotech companies recognise
Does this sound
familiar?
Why this hits pharmaceutical & biotech companies hardest
Sector-specific
pressure points.
Brand not communicating scientific rigour and clinical credibility to investors and KOLs
No digital strategy for building awareness with HCPs before a product launch
Website failing to explain complex mechanism-of-action in terms stakeholders understand
No content strategy building authority in a competitive therapeutic area
Our approach
How we fix it
for pharmaceutical & biotech companies.
Content Audit
We review what's been published against actual keyword opportunity and search intent to see what's worth fixing versus what's worth cutting.
Keyword & Intent Strategy
We build a content plan around terms your actual buyers search, with enough search volume and intent to be worth the effort.
Content That Out-Competes
We create or rework content to be genuinely better than what currently ranks, not just longer.
Distribution & Tracking
We put a distribution plan and tracking in place so new content gets seen, and its impact on traffic and pipeline is measurable.
What pharmaceutical & biotech companies gain
Real outcomes.
A content strategy built around terms that actually drive qualified traffic
Existing content reworked to compete for its target keywords
Clear visibility into which content drives real business results
FAQ
Common questions.
Do you specifically fix content not driving traffic for pharmaceutical & biotech companies?
Yes. We understand the specific commercial context pharmaceutical & biotech companies operate in, and we apply that context directly to how we fix content not driving traffic.
What causes content not driving traffic for a pharmaceutical & biotech?
Content targeting keywords with low search volume or low buyer intent These issues tend to compound for pharmaceutical & biotech companies because of brand not communicating scientific rigour and clinical credibility to investors and kols.
How quickly can you fix content not driving traffic for our pharmaceutical & biotech?
Most engagements addressing content not driving traffic for pharmaceutical & biotech companies show measurable movement within 30–60 days, with the full fix delivered over 4–10 weeks depending on scope.
What results should a pharmaceutical & biotech expect?
A content strategy built around terms that actually drive qualified traffic Existing content reworked to compete for its target keywords
Do you work with pharmaceutical & biotech companies outside our home market?
Yes - we work with pharmaceutical & biotech companies across North America, the UK, UAE, Europe, and Asia Pacific, delivered fully remotely.
Explore more
Related pages.
Other Problems We Solve for Pharmaceutical & Biotech Companies
Content Not Driving Traffic for Pharmaceutical & Biotech Companies
Ready to fix
this for your pharmaceutical & biotech?
Book a discovery call. No pitch, no pressure - just a focused conversation about where you are and where you want to be.